New Paradigms to Improve Outcomes in Head and Neck Cancer The Evolving Roles of Induction Chemotherapy, Chemoradiotherapy, and Sequential Therapy Marshall.
Marshall R. Posner, MD Dana-Farber Cancer Institute
New Aspects in Oropharyngeal Cancer Jan B. Vermorken, MD, PhD Antwerp University Hospital Edegem, Belgium Statements on Head and Neck Cancer Saturday,
